How does 1JV1's PS Ratio compare to its peers?

1JV1 is good value based on its Price-To-Sales Ratio (6.6x) compared to the peer average (7.4x).

How does 1JV1's PS Ratio compare vs other companies in the European Pharmaceuticals Industry?

1JV1 is expensive based on its Price-To-Sales Ratio (6.6x) compared to the European Pharmaceuticals industry average (3x).

What is 1JV1's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate 1JV1's Price-To-Sales Fair Ratio for valuation analysis.

What is the Fair Price of 1JV1 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate 1JV1's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

1JV1 Stock Overview

Engages in the production and distribution of cannabis product for medical and recreational use in Canada. More details

1JV1 fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap (€854K)

Makes less than USD$1m in revenue (CA$129K)

Negative shareholders equity

Shares are highly illiquid

+ 2 more risks

My Notes

Capture your thoughts, links and company narrative

Gnomestar Craft Inc. Competitors

Biofrontera

XTRA:B8FK

€14.0m

Vitruvia Medical

MUN:991

€2.3m

Epigenomics

DB:ECX

€971.4k

Redx Pharma

DB:0RX

€65.0m

Price History & Performance

Summary of share price highs, lows and changes for Gnomestar Craft
Historical stock prices
Current Share Price	CA$0.0005
52 Week High	CA$0.021
52 Week Low	CA$0.0002
Beta	1.87
1 Month Change	0%
3 Month Change	-66.67%
1 Year Change	-96.88%
3 Year Change	-97.62%
5 Year Change	-99.90%
Change since IPO	-99.95%

Recent updates

Shareholder Returns

	1JV1	DE Pharmaceuticals	DE Market
7D	0%	-2.2%	-2.0%
1Y	-96.9%	-15.6%	6.9%

Return vs Industry: 1JV1 underperformed the German Pharmaceuticals industry which returned -28.2% over the past year.

Return vs Market: 1JV1 underperformed the German Market which returned 5.9% over the past year.

Price Volatility

Is 1JV1's price volatile compared to industry and market?
1JV1 volatility
1JV1 Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	5.5%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.3%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: 1JV1's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine 1JV1's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2011	n/a	Mark Lotz	gnomestarcannabis.com

Gnomestar Craft Inc. engages in the production and distribution of cannabis product for medical and recreational use in Canada. The company was formerly known as Vodis Pharmaceuticals Inc. and changed its name to Gnomestar Craft Inc. in December 2020. Gnomestar Craft Inc. was incorporated in 2011 and is based in Delta, Canada.

Gnomestar Craft Inc. Fundamentals Summary

How do Gnomestar Craft's earnings and revenue compare to its market cap?
1JV1 fundamental statistics
Market cap	€589.99k
Earnings (TTM)	-€503.74k
Revenue (TTM)	€88.95k

6.6x

P/S Ratio

-1.2x

P/E Ratio

Is 1JV1 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1JV1 income statement (TTM)
Revenue	CA$128.77k
Cost of Revenue	CA$795.95k
Gross Profit	-CA$667.18k
Other Expenses	CA$62.07k
Earnings	-CA$729.25k

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0085
Gross Margin	-518.12%
Net Profit Margin	-566.32%
Debt/Equity Ratio	-2.8%

How did 1JV1 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/01/03 00:19
End of Day Share Price	2022/10/06 00:00
Earnings	2021/12/31
Annual Earnings	2021/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Gnomestar Craft Inc. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution